{
    "title": "US FDA declines to approve first nasal spray equivalent of EpiPen",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12538813/US-FDA-declines-approve-nasal-spray-equivalent-EpiPen.html",
    "date": "2023-09-20",
    "keywords": [
        "spray",
        "nasal",
        "treatment",
        "fda",
        "health",
        "drug",
        "anaphylaxis",
        "response",
        "action",
        "vote",
        "lowenthal",
        "favor",
        "application",
        "half",
        "rhinitis",
        "realworld",
        "viatris",
        "emergency",
        "move",
        "developer",
        "neffy",
        "auviq",
        "epinephrine",
        "risk",
        "food",
        "administration",
        "letter",
        "company",
        "repeatdose",
        "study",
        "approval",
        "tuesday",
        "requirement",
        "time",
        "committee",
        "statement",
        "panel",
        "date",
        "decision",
        "companys",
        "attack",
        "lack",
        "concern",
        "allergist",
        "texas",
        "tech",
        "university",
        "center",
        "june",
        "apprvedunder",
        "test",
        "reporting",
        "santhosh",
        "sriparna",
        "roy",
        "jahnavi",
        "nidumolu",
        "bengaluru",
        "editing",
        "maju",
        "samuel",
        "dhanya",
        "ann",
        "thoppil",
        "varun",
        "h",
        "k"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}